Ella Daly
Impact in
- Biological Psychiatry top 0.1%
- Tryptophan and brain disorders
- Pharmacology top 0.1%
- Treatment of Major Depression
Papers in
- Pharmacology 49
- Treatment of Major Depression 48
-
- Tryptophan and brain disorders 10
- Co-authors
- Jaskaran B. Singh (30 shared papers)Wayne Curtis Drevets (29 shared papers)Madhukar H. Trivedi (19 shared papers)Husseini K. Manji (18 shared papers)Pilar Lim (18 shared papers)Maggie M Fedgchin (13 shared papers)Kimberly Cooper (6 shared papers)Luc Van Nueten (8 shared papers)
- Journals
- European Neuropsychopharmacology (11 papers)American Journal of Geriatric Psychiatry (5 papers)American Journal of Psychiatry (4 papers)The Journal of Clinical Psychiatry (4 papers)Journal of Affective Disorders (3 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Ella Daly
69 papers receiving 4.5k citations
Ella Daly's Hit Papers
Peers
Comparison fields: 5 of 111
- Biological Psychiatry 1.5k
- Pharmacology 3.2k
- Behavioral Neuroscience 178
- Psychiatry and Mental health 622
- Cellular and Molecular Neuroscience 723
Countries citing papers authored by Ella Daly
This map shows the geographic impact of Ella Daly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Daly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Daly more than expected).
Fields of papers citing papers by Ella Daly
This network shows the impact of papers produced by Ella Daly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Daly. The network helps show where Ella Daly may publish in the future.
Co-authors
The 25 scholars most cited alongside Ella Daly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression Hit paper breakdown → | 2017 | 575 |
| 2 | Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study Hit paper breakdown → | 2019 | 559 |
| 3 | Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression Hit paper breakdown → | 2019 | 469 |
| 4 | A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression Hit paper breakdown → | 2016 | 428 |
| 5 | Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study Hit paper breakdown → | 2015 | 377 |
| 6 | Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1) Hit paper breakdown → | 2019 | 352 |
| 7 | Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3 Hit paper breakdown → | 2019 | 258 |
| 8 | Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression Hit paper breakdown → | 2020 | 244 |
| 9 | 2010 | 147 | |
| 10 | 2013 | 104 | |
| 11 | 2007 | 90 | |
| 12 | 2012 | 81 | |
| 13 | 2009 | 76 | |
| 14 | 2020 | 61 | |
| 15 | Treatment strategies to improve and sustain remission in major depressive disorder. | 2008 | 60 |
| 16 | 2016 | 47 | |
| 17 | 2009 | 44 | |
| 18 | 2020 | 37 | |
| 19 | 2021 | 33 | |
| 20 | 2021 | 31 |
About Ella Daly
Ella Daly is a scholar working on Pharmacology, Biological Psychiatry, Sensory Systems, Experimental and Cognitive Psychology and Psychiatry and Mental health, having authored 71 papers that have together received 4.6k indexed citations. Recurring topics across this work include Treatment of Major Depression (48 papers), Tryptophan and brain disorders (10 papers), Olfactory and Sensory Function Studies (9 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers), Mental Health Research Topics (6 papers), Neurotransmitter Receptor Influence on Behavior (5 papers), Schizophrenia research and treatment (5 papers) and Digital Mental Health Interventions (3 papers). The work is most often cited by research in Biological Psychiatry (1.5k citations), Pharmacology (3.2k citations), Behavioral Neuroscience (178 citations), Psychiatry and Mental health (622 citations) and Cellular and Molecular Neuroscience (723 citations). Ella Daly has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Jaskaran B. Singh, Wayne Curtis Drevets, Madhukar H. Trivedi, Husseini K. Manji, Pilar Lim, Maggie M Fedgchin, Kimberly Cooper, Luc Van Nueten, Michael E. Thase and David W. Hough. Their work appears in journals such as European Neuropsychopharmacology, American Journal of Geriatric Psychiatry, American Journal of Psychiatry, The Journal of Clinical Psychiatry and Journal of Affective Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.